- About EAS
|European Lipoprotein Club (ELC)|
The ELC's Mission
The European Lipoprotein Club (ELC) was established in 1977 in order "to promote active participation, collaboration and exchange of ideas concerning basic and clinical research on the structure, function and metabolism of lipoproteins in health and disease".
The ELC today
The ELC currently comprises over 500 scientists from more than 20 countries in Europe and abroad, and the number grows every year. The ELC is thus a worldwide network of basic scientists and clinicians involved in lipoprotein research. The network is strengthened and expanded by contacts established at the ELC meetings, and fostered by the exchange of ideas, clinical material, techniques and young visiting investigators. To the 39th annual scientific ELC meeting, 5-8 September, 2016.
The ELC organisation and governance
The European Lipoprotein Club is based on individual membership. Scientists and students
Scientific meeting in Tutzing
The ELC organises one scientific meeting every year (usually in the second week of September), with particular emphasis on an active participation and in-depth discussion in an informal atmosphere. Since 1980 the meetings have been held at the Evangelische Akademie in Tutzing, Germany. An organising committee, currently of 12 members, representing as many different European countries as possible, arranges the meetings. These representatives are elected by the members and serve for 5 years. One representative acts as the chairman of the Club and has the major responsibility for the organisation of the meeting. From 1980 to 2011, the local organisation of the meeting has been in the hands of the late Dr. Joachim Ziegenhorn and his colleagues from Boehringer Mannheim/Roche. Since 2012 the local organisation has been undertaken by Dr. Joachim Siedel.
The current chairman is Professor Anne Tybjaerg-Hansen, Copenhagen, Denmark. Dr. Barbara Fielding from Surrey, United Kingdom, acts as treasurer. Three to five topics, selected by the organising committee, are discussed at each meeting, in five working sessions spread over four days, starting with a Keynote Lecture by an invited speaker on Monday evening. Anyone interested and involved in research in the lipoprotein field is invited to submit an abstract for the meeting. Participants are selected on the relevance and scientific merit of their abstracts, and approximately 30 of those attending the meeting are chosen to give an oral presentation. Because of the size of the lecture hall, and in order to maintain an atmosphere conducive to active discussion, participants are limited to 110.
For many years, the ELC has been generously supported by Boehringer Mannheim, to the extent that all housing, dining and other conference facilities have been taken care of. At the 1998 meeting, after the take-over of Boehringer-Mannheim by F.Hoffmann-LaRoche, representatives from Roche have generously continued the support of the ELC. During recent years, sponsorship has been received from AstraZeneca, Boehringer Ingelheim, German Research Foundation, GlaxoSmithKline, Merck Sharpe and Dohme, Sanofi Aventis, Genfit, Mabtech, Atherosclerosis, Clinical Science, Unilever, Amgen, and COST - European Cooperation in Science and Technology. Since 2013 a major sponsor of the ELC has been the European Atherosclerosis Society, allowing to sustain the high quality of the meetings.